JAZZ vs. SMG
Compare and contrast key facts about Jazz Pharmaceuticals plc (JAZZ) and The Scotts Miracle-Gro Company (SMG).
Performance
JAZZ vs. SMG - Performance Comparison
Loading graphics...
JAZZ vs. SMG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JAZZ Jazz Pharmaceuticals plc | 10.75% | 38.04% | 0.12% | -22.79% | 25.05% | -22.81% | 10.56% | 20.43% | -7.94% | 23.50% |
SMG The Scotts Miracle-Gro Company | 5.56% | -8.01% | 8.28% | 36.92% | -68.81% | -18.03% | 96.18% | 77.05% | -41.00% | 14.46% |
Fundamentals
JAZZ:
$11.48B
SMG:
$3.53B
JAZZ:
-$5.81
SMG:
$1.55
JAZZ:
2.70
SMG:
1.06
JAZZ:
$4.27B
SMG:
$3.35B
JAZZ:
$5.11B
SMG:
$1.04B
JAZZ:
$835.63M
SMG:
$447.10M
Returns By Period
In the year-to-date period, JAZZ achieves a 10.75% return, which is significantly higher than SMG's 5.56% return. Over the past 10 years, JAZZ has outperformed SMG with an annualized return of 3.47%, while SMG has yielded a comparatively lower 1.42% annualized return.
JAZZ
- 1D
- -0.41%
- 1M
- -1.15%
- YTD
- 10.75%
- 6M
- 37.52%
- 1Y
- 50.63%
- 3Y*
- 8.76%
- 5Y*
- 2.65%
- 10Y*
- 3.47%
SMG
- 1D
- 0.33%
- 1M
- -13.31%
- YTD
- 5.56%
- 6M
- 6.84%
- 1Y
- 16.38%
- 3Y*
- -0.16%
- 5Y*
- -21.80%
- 10Y*
- 1.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JAZZ vs. SMG — Risk / Return Rank
JAZZ
SMG
JAZZ vs. SMG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jazz Pharmaceuticals plc (JAZZ) and The Scotts Miracle-Gro Company (SMG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JAZZ | SMG | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.23 | 0.43 | +0.81 |
Sortino ratioReturn per unit of downside risk | 2.01 | 0.85 | +1.15 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.11 | +0.17 |
Calmar ratioReturn relative to maximum drawdown | 2.28 | 0.68 | +1.60 |
Martin ratioReturn relative to average drawdown | 5.53 | 1.31 | +4.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| JAZZ | SMG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.23 | 0.43 | +0.81 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.08 | -0.48 | +0.56 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.11 | 0.04 | +0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | 0.22 | -0.04 |
Correlation
The correlation between JAZZ and SMG is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
JAZZ vs. SMG - Dividend Comparison
JAZZ has not paid dividends to shareholders, while SMG's dividend yield for the trailing twelve months is around 4.33%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JAZZ Jazz Pharmaceuticals plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SMG The Scotts Miracle-Gro Company | 4.33% | 4.52% | 3.98% | 4.14% | 5.43% | 1.59% | 3.72% | 2.13% | 3.51% | 1.93% | 2.03% | 2.85% |
Drawdowns
JAZZ vs. SMG - Drawdown Comparison
The maximum JAZZ drawdown since its inception was -96.90%, which is greater than SMG's maximum drawdown of -83.55%. Use the drawdown chart below to compare losses from any high point for JAZZ and SMG.
Loading graphics...
Drawdown Indicators
| JAZZ | SMG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.90% | -83.55% | -13.35% |
Max Drawdown (1Y)Largest decline over 1 year | -22.67% | -23.85% | +1.18% |
Max Drawdown (5Y)Largest decline over 5 years | -47.55% | -83.55% | +36.00% |
Max Drawdown (10Y)Largest decline over 10 years | -52.10% | -83.55% | +31.45% |
Current DrawdownCurrent decline from peak | -4.35% | -71.06% | +66.71% |
Average DrawdownAverage peak-to-trough decline | -27.65% | -20.88% | -6.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.34% | 12.27% | -2.93% |
Volatility
JAZZ vs. SMG - Volatility Comparison
The current volatility for Jazz Pharmaceuticals plc (JAZZ) is 7.72%, while The Scotts Miracle-Gro Company (SMG) has a volatility of 14.01%. This indicates that JAZZ experiences smaller price fluctuations and is considered to be less risky than SMG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| JAZZ | SMG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.72% | 14.01% | -6.29% |
Volatility (6M)Calculated over the trailing 6-month period | 29.45% | 22.89% | +6.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.23% | 38.62% | +2.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.51% | 45.95% | -14.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.72% | 40.05% | -7.33% |
Financials
JAZZ vs. SMG - Financials Comparison
This section allows you to compare key financial metrics between Jazz Pharmaceuticals plc and The Scotts Miracle-Gro Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities